Pilot study to assess physical exercise intervention in neoadjuvant treatment with nab-paclitaxel in patients with triple negative breast cancer - OncoExer

Fundación de Investigación HM Hospitales0 个研究点开始时间: 2017年6月9日最近更新: 2017年8月21日

试验速览

暂无简介。

•1.- Women with TNBC stages II and III (A, B).
•2.- Women = 18 years old.
•3.- Patients with a tumor size = 2 cm, N0, N1-2.
•4.- Patients able to start a physical exercise program (if randomized to that arm) in the same week that starting neoadjuvant chemotherapy.
•5.- Patientes that dedicate < 60 minutes of physical activity per week.
•6.- Patients that declare to be not smokers/drinker at the time of diagnosis.
•7.- Patients with Cholesterol value <200 at the time of diagnosis.
•8.- Patients No diagnosed with hyperthyroidism or hypothyroidism.
•9.- No diagnosed with diabetes.
•10.- Patients with an echocardiogram > 50%.
•11.- Bone mass index between 18,5 and 25.
•12.- No additional treatments that might interfere with the current protocol.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 20
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•1.- Patients with a history of chronic disease (Diabetes, not controlled high blood pressure, thyroid disease).
•2.- Patients with a weight loss >10% in the past 6 months.
•3.- Patients with metastatic disease.
•4.- Patients with cardiovascular, pulmonary or biomotor problems that might contraindicate physical exercise.
•5.- Patients that declare to be smokers/drinker at the time of diagnosis.
•6.- Patients with Cholesterol value >200 at the time of diagnosis.
•7.- Patients diagnosed with hyperthyroidism or hypothyroidism.
•8.- Patients diagnosed with diabetes.
•9.- Patients with an echocardiogram < 50%.
•10.- Patientes with additional treatments that might interfere with the current protocol.

发起方

Fundación de Investigación HM Hospitales